EricKumarSinghiMD

Thoracic/Head & Neck Medical Oncologist, Assistant Professor at MD Anderson Cancer Center

Dr. Singhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Fax+1 713-792-3708

Dr. Eric K. Singhi is a thoracic/head and neck medical oncologist and Assistant Professor at the University of Texas MD Anderson Cancer Center. He received his medical degree from the Medical University of South Carolina College of Medicine and completed his Internship and Residency training in Internal Medicine at Vanderbilt University. He subsequently completed his hematology and medical oncology fellowship training at the University of Texas MD Anderson Cancer Center, serving as Chief Education Fellow. He also speaks multiple languages, including Hindi and Spanish. He specializes in General Internal Medicine and Hematology/Oncology. He has an interest in thoracic medical oncology, patient-reported outcomes, patient education, and community outreach.

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2022
Vanderbilt University Medical CenterInternship, Internal Medicine, 2016 - 2017
Medical University of South CarolinaClass of 2016
Duke UniversityBS, Neuroscience, Spanish, Genome Sciences, Magna Cum Laude, Phi Beta Kappa, Graduation with Distinction, 2008 - 2012

PubMed

37 citations
Lung Cancer Treatment Advances in 2022.
Fawzi Abu Rous, Eric K Singhi, Arthi Sridhar, Muhammad Salman Faisal, Aakash Desai
Cancer Investigation. 2023-01-01
30 citations
Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.
Eric K Singhi, Leora Horn, Lecia V. Sequist, John V. Heymach, Corey J. Langer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2019-05-17
173 citations
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease
Arvind K. Pandey, Eric K. Singhi, Juan Pablo Arroyo, Talat Alp Ikizler, Edward R. Gould
Hypertension. 2018-02-01

Journal Articles

“Triple-triple” hit lymphoma
Mushtaq S, Singhi EK, Stuart R, Case Reports in Internal Medicine, 10/2015
Addressing tobacco use at NCI designated cancer centers: Online resources available for patients.
Eric K. Singhi, Alix W. Pommerenke, Sarah Mushtaq, Kenneth Michael Cummings, James Roger Marshall, Anthony Alberg, and Graham Walter Warren, Journal of Clinical Oncology, 2015

Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma,,✰✰✰,✰✰✰✰☆✰✰✰✰May 2018
Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma,,✰✰✰,✰✰✰✰☆✰✰✰✰May 2018

IASLC 2024 World Conference on Lung Cancer: Dr. Singhi Discusses Highly Anticipated SessionsAugust 27th, 2024
FDA Approvals Create “Difficult Decisions” in Early-Stage Resectable NSCLCAugust 26th, 2024
Are Subcutaneous Drugs the Key to Cancer Care’s Future?August 20th, 2024
Join now to see all